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Abstract 
Ethnopharmacological relevance: Three important Anglo-Saxon medical texts from 
the 10th century contain herbal formulations for over 250 plant species, many of 
which have yet to be evaluated for their phytochemical and/or pharmacological 
properties. In this study, three native British plants were selected to determine 
antimicrobial activity relevant to treating bacterial infections and wounds. 
Materials and methods: Several preparations of Agrimonia eupatoria L., Arctium 
minus (Hill) Bernh. and Potentilla reptans L. were screened for antimicrobial activity 
against selected Gram-positive and Gram-negative bacteria of relevance in wounds 
using a 96 well plate microdilution method (200, 40 and 8 µg/mL). Minimum inhibitory 
concentration (MIC) values were determined for the most potent extracts from 2-
0.004 mg/mL and HPLC chromatograms examined by multivariate analysis. Principle 
components analysis (PCA) was used to identify chemical differences between 
antimicrobial activity of the crude extracts. 
Results: The HPLC-PCA score plots attributed HPLC peaks to the antimicrobial 
activity with all three plants inhibiting growth of Gram-positive Staphylococcus 
aureus by >50% in four or more extracts. The first two principal components (PC) 
represented 87% of the dataset variance. The P. reptans 75% ethanol root extract 
exhibited the greatest range of activity with MIC50 at 31.25 µg/mL to a total MIC that 
was also the minimum bactericidal concentration (MBC) at 1 mg/mL. Additionally, the 
root of P. reptans inhibited growth of Gram-negative bacteria with the 75% ethanol 
extract having a MIC50 at 1 mg/mL against Pseudomonas aeruginosa and the 
decoction a MIC50 at 3.9 µg/mL against Escherichia coli. 
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Conclusions: The results indicate a moderate antimicrobial activity against common 
wound pathogens for P.reptans suggesting it may well have been effective for 
treating wound and bacterial infections. Anglo-Saxon literary heritage may provide a 
credible basis for researching new antimicrobial formulations. Our approach 
encompassing advanced analytical technologies and chemometric models paves the 
way for systematic investigation of Anglo-Saxon medical literature for further 
therapeutic indications to uncover knowledge of native British plants, some of which 
are currently lost to modern Western herbal medicine.  
 
1. Introduction  
Three important Anglo-Saxon medical texts based on herbal formulations 
were compiled in England during the 10th century. The Old English herbarium, a 
classical Latin text (4-5th century) containing many ‘simples’ or single formulations 
was reordered and translated into Old English. Bald’s Leechbook and the Lacnunga, 
by contrast, were written in the vernacular with no known Latin variants and include 
formulations from a variety of sources including Latin and Greek; Old Irish and 
Aramaic (Voigts, 1979; Pettit, 2001 and Cameron, 2006). Bald’s Leechbook 
combines the best of classical and indigenous teachings into a coherent text suitable 
for attending the royal household whereas the Lacnunga is considered to be a 
personal collection of formulations used by a lay practitioner. (Talbot,1967; Pettit, 
2001, Pollington, 2008 and Meaney, 1984). Later European herbals from 16th and 
17th centuries have been reviewed for rheumatism treatments (Adams et al., 2009) 
with reported activities that seem to support at least some of these historical 
formulations that have been handed down through the centuries. 
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Despite a rich history of medicinal plant use throughout the British Isles, much 
of the native flora listed in the Anglo-Saxon medicinal literature has yet to be 
evaluated for pharmacological and medicinal applications (Watkins et al., 2011). 
Following Cockayne’s translation of all the major Anglo-Saxon medical literature 
(1864-1865) many of the formulations were dismissed by medical scholars as having 
‘little or no value to medical understanding’ (Cameron, 2006). There have been a 
number of calls to research the ancient medical literature (Riddle, 1985; 
Holland,1996 and Buenz et al., 2004) but to date little has resulted in scientific 
investigation of the Anglo-Saxon herbal texts. Cameron (2006, 2008) sought to 
review the scientific literature in support of his hypothesis that the Anglo-Saxons 
were more advanced in their medical treatments than previously thought. However, 
no primary experimental data was provided by Cameron and more recent 
examination of the historical medical texts has fallen short of scientific scrutiny in a 
laboratory setting (Buenz et al., 2004, Thomas, 2011). Brennessel et al. (2005) 
reported poor antimicrobial activity for selected Anglo-Saxon medicinal preparations 
however, the report does not provide all the concentrations at which these were 
tested and full experimental methods and data have not since been published. The 
objective of this study is to experimentally determine the in vitro antimicrobial activity 
of selected plants used by the Anglo-Saxon herbal practitioner to treat wounds and 
bacterial infections.  
2.  Materials and Methods 
2.1.  Anglo-Saxon Medical Texts 
  An initial search of the Anglo-Saxon medical literature was conducted via the 
British Library online catalogue using keywords Anglo-Saxon medicine (29 hits), 
Anglo-Saxon herbals (4) and Anglo-Saxon medical texts (6) in order to find modern 
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English translations of the surviving Anglo-Saxon medical literature. Further 
searches using the same keywords were undertaken in the academic journal 
databases JSTOR, Science Direct and ISIS Web of Knowledge. The Old English 
herbarium was chosen as the initial data source and three translations consulted: 
Leechdoms, wortcunning, and starcraft of early England (Cockayne, 1864); Medieval 
herbal remedies: the Old English Herbarium and Anglo-Saxon medicine (van Arsdall, 
2002) and Leechcraft: early English charms, plant-lore and healing (Pollington, 
2008). Both Bald’s Leechbook and the Lacnunga were reviewed for plant names in 
single plant and combination formulations used to treat bacterial infections and 
wounds. Two translations of Bald’s Leechbook were examined (Cockayne, 1864 and 
Pollington, 2008) and three works reviewing the texts consulted (Meaney, 1984; 
Deegan, 1988 and Cameron, 2008). A comprehensive translation of the Lacnunga 
by Pettit (2001) titled Anglo-Saxon remedies, charms and prayers from British 
Library MS Harley 585 was used and supported by evidence from three other works 
(Cockayne, 1864; Cameron 2008 and Pollington, 2008).  
2.2. Plant selection criteria 
Native British plants not subject to any conservation orders were selected if 
they were assigned both an Anglo-Saxon and Latin name in the Old English 
Herbarium and listed for the treatment of at least two external conditions whereby 
bacteria would have been present including a puncture wound (battle injury, animal 
or insect bite), burn, ear, nose or throat infection and boil or ulcer.  A study of plant 
names from medieval manuscripts (Hunt, 1989) was used to confirm common and 
vernacular names and then cross referenced in Bald’s Leechbook and the Lacnunga 
for medicinal use in herbal formulations (Cockayne, 1864; Pettit, 2001; Pollington, 
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2008). A phytochemistry literature search was conducted  in Isis Web of Knowledge, 
Pub Med and Science Direct databases followed by specific journal searches in 
antimicrobial and phytochemical publications for potential plant candidates using 
keywords, Latin and/or common plant names + ‘antimicrobial’. The NapralertSM 
relational database (University of Illinois at Chicago, USA) was accessed for 
published research in English on ethno-medical studies, biological tests and known 
phytochemical compounds from which three plants of under reported phytochemistry 
were chosen for the antimicrobial assays.  
2.3. Plant collection 
Potential locations were sourced from ‘Flora of Hertfordshire’ (James, 2010) 
and field trips conducted in June - August 2010 and 2011 to identify viable plant 
colonies, obtain landowner permissions (according to 1981 Wildlife and Countryside 
Act) and subsequently harvest the plant material. Chosen sites were within a 25 mile 
radius of Watford, Hertfordshire  in areas typical of where an Anglo-Saxon may have 
collected wild specimens. Depending on plant size, 3-9 specimens of each species 
were harvested at one or more locations for laboratory analysis and data recorded 
for the herbarium label (see supplementary data) including geographic location, 
elevation, date and time of collection. Additionally, two specimens were pressed and 
dry mounted; authenticated by an independent botanist and deposited as voucher 
specimens in the herbarium at Kew Royal Botanic Gardens: Arctium minus (Hill) 
Bernh. (Asteraceae) - FMW003was collected at TQ05907 in August 2010 and 
Agrimonia eupatoria  L. (Rosaceae) -FMW001 and Potentilla reptans L. (Rosaceae) - 
FMW002 were collected in August 2010 and 2011 at TL06526 and TL06398 
respectively.  
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2.4. Preparation of crude extracts  
Plant material was separated into aerial parts and roots for each species and 
air dried in a cool dark room for five days followed by 48 h in a fan assisted oven 
(Gallenkamp) at 40°C; cooled and ground to a rough powder using an electric 
blender and refined using a 500 µm sieve. Two grams of aerial parts and roots were 
separately macerated for 24 h in 20 mL solvent (red wine, 25% or 75% EtOH in H2O) 
making a total of four ethanol and two wine extractions for each plant. A 2007 
Cabernet Sauvignon at 14% proof from Northern Israel (Barkan Classic, barcode: 
7290000023809) was used to represent a berry wine which can reach 18% proof 
when made with mead (Hagen, 2006). This red wine blank was used as a control. 
The infusion was prepared by adding 40 mL boiling H2O to 2 g of dried aerial parts 
and left for 10 min. For the decoction, 100 mL H2O was added to 2 g of roots, boiled 
then simmered for 20 min and reduced to a third. The supernatant for each crude 
extract was filtered and evaporated to 5 mL using reduced pressure (Buchi Syncore) 
at 45°C, transferred to a weighed vial and placed on a drying block (Techne Dri-
block) at 40°C for 1-2 days to yield a dried crude extract. Stock solutions of crude 
extract were prepared at 20 mg/mL in DMSO using an ultrasonic water bath 
(QHKerry) for 30 min and stored at 4°C for further use.  
2.5 Antimicrobial assay  
Chloramphenicol, dimethyl sulphoxide (DMSO), formic acid, HPLC grade 
ethanol and methanol were obtained from Fisher Scientific UK Ltd; nutrient broth 
(CM0001) and nutrient agar (CM0003) from Oxoid Limited and distilled water purified 
using a reverse osmosis system (Purelab Option S). The bacteria strains used for 
testing the antimicrobial activity were Gram-positive Staphylococcus aureus (NCTC 
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7447) and Bacillus subtilis (NCTC 3610) and Gram-negative bacteria Escherichia 
coli (UEL 57) and Pseudomonas aeruginosa (NCIB 8295). Four to five colonies were 
transferred from nutrient agar plates to 5 mL sterile nutrient broth and incubated at 
37°C overnight. The bacteria concentration was standardised by using a 
spectrometer (Jenway 6305) for optical density readings of 0.1 at 600 nm equivalent 
to 1.5 x 106 colony forming units (CFUs) and diluting inoculums in sterile nutrient 
broth (Kuete et al., 2009). The four bacteria were screened for antimicrobial activity 
using the microdilution method in round bottomed 96 well microtitre plates (NCCLS, 
2009). Wells were filled with 100 µL plant extract, 95 µL nutrient broth and 5 µL 
inoculum with final concentrations of 200, 40 and 8 µg/mL (Rios and Reico, 2005 
and Cos et al., 2006). Each experiment was run in quadruplicate and repeated on 
three independent days (n=3). Bacterial growth was determined by taking optical 
density readings (Multiskan Spectrum) at 600 nm at 0 h (t1) and 18 h (t2) following 
incubation at 37°C. The percentage of bacterial growth inhibition was calculated by 
t2-t1/mean of inoculum and nutrient broth cells x 100. 
The MIC values of the most potent crude plant extracts from the antimicrobial 
screening were determined by the microdilution method. Dried extract (48 mg) was 
reconstituted in 1 mL DMSO and sonicated for 30 min, diluted in 11 mL sterile 
nutrient broth and serially diluted to give ten final well concentrations ranging from 2– 
0.004 mg/mL. Chloramphenicol was used as the postive control at the same 
concentrations and nutrient broth with 1% DMSO, the negative control. Each dilution 
was performed in quadruplicate and repeated on three different days (n=3). MIC 
values were determined by using optical density readings at 600 nm taken at 0 h and 
18 h. A percentage inhibition was calculated using the same formula as for the 
antimicrobial screening with >99% inhibition determined as a full MIC value; MIC50 
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and MIC90 being 50% and 90% inhibition of bacterial growth. To confirm MBC a loop 
was inserted into the wells with no visible growth and streaked onto an agar plate, 
incubated at 37°C for 18 h and checked for any bacterial growth.  
2.6. HPLC and Principal Components Analysis (HPLC-PCA) 
The HPLC system (Agilent 1200 series) comprised a Quaternary pump 
(G1311A), degasser (G13221), autosampler (G1329A), column oven (G1316A) and 
diode-array detector (G1316A). Two hundred microlitres of stock solution (20 
mg/mL) were centrifuged at 13,000 rpm for 5 min and 100 µL transferred to HPLC 
vial and diluted tenfold in 900 µL starting mobile phase (Sanchez-Medina et al., 
2007). Solvent controls were prepared for DMSO, methanol and red wine. UV data 
were acquired from 200-360 nm with 210 nm, 254  nm and 320  nm wavelengths selected 
for monitoring. A Zorbax Eclipse C18 analytical column (150 x 4.6 mm id) was 
maintained in the column oven at 25°C using a flow rate of 1 mL/min. The starting 
mobile phase comprised aqueous 0.01% formic acid in distilled water (A) and 
methanol (B) with initial conditions set at 25% B with a linear gradient to 90% B at 30 
min and retained for 2 min. The gradient returned to 25% B at 34 min and the 
column was equilibrated for 6 min giving a total gradient cycle of 40 min. The sample 
injection was 20 µL performed in triplicate. HPLC chromatograms for each crude 
extract were generated in Agilent 1200 Chemstation software (Rev B.04.01) at 210 
nm, 254 nm and 320 nm  and the data exported as comma separated value files (.CSV) 
into SIMCA-P+ 12.00 (Umetrics, Sweden) software. The HPLC-PCA profiles or 
patterns of the secondary metabolites were generated by multivariate analysis. PCA 
a commonly used algorithm to discern differences between large amounts of data 
was employed to verify the quality of the HPLC data, correlate the chemistry with the 
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inhibitory growth of the wound pathogens and identify HPLC peaks attributed to the 
antimicrobial activity (Gao et al., 2010).  
3.  Results  
The broad keywords identified the lack of scientific evidence regarding the 
Anglo-Saxon medical literature and that a number of translations would have to be 
read in order to appreciate the context in which the herbal formulations were used. 
The Old English Herbarium was the most appropriate for the basis of the selection 
criteria in that it comprised mainly single plant preparations whereby outcomes could 
be attributable to a named plant. The text includes 185 plants of which 140 were 
assigned both Latin and Anglo-Saxon names. Thirty were native British plants 
(Stace, 2010) listed for the treatment of puncture wound, open wound, burn, ear 
nose or throat infection, boil or ulcer; 12 plants were used as simple and in 
combination formulations in all three texts and following the phytochemical and 
ethno-medical search (supplementary data) three plants having under reported 
phytochemistry were selected for the antimicrobial study: A. minus, A. eupatoria and 
P. reptans. The 10th century literature references for formulations specifying these 
three plants to treat wounds and bacterial infections compared with modern Western 
herbal applications are reported in Table 1.  
In the antimicrobial screen against Gram-positive organisms all three plants 
(Fig. 1.) demonstrated >50% inhibition of S. aureus in four or more of the eight 
extracts at 200 µg/mL. Each plant also showed one or more of the ethanol root 
extracts to inhibit growth at 40 µg/mL with dose response activity across the majority 
of root extracts.  For A. minus only the 25% root extract exhibited >60% inhibition of 
S. aureus at 40 µg/mL and >50% activity at 200 ug/mL against B. subtilis in leaf and 
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root extracts (data not shown). A. eupatoria demonstrated greater activity against S. 
aureus with >58% inhibition at 200 µg/mL across all the preparations except the wine 
extracts and >61% inhibition of B. subtilis at 200 µg/mL in the ethanol and aqueous 
root extracts (data not shown). P. reptans was the only plant to demonstrate >50% 
inhibition of S.aureus at 8 µg/mL in the 75% ethanol root extract and 68% inhibition 
at 40 µg/mL in the 25% ethanol root extract (Fig.1.).  The greatest activity of P. 
reptans against B. subtilis was the 25% ethanol leaf exhibiting 60% inhibition at 40 
µg/mL (data not shown). None of the plants demonstrated >50% inhibition of Gram-
negative P. aeruginosa at the screening concentrations. However, A. eupatoria and 
P. reptans both inhibited growth of E.coli by >60% at 200 µg/mL in the decoctions 
and 25% ethanol root extracts.  
The HPLC-diode array chromatograms in Fig. 2. illustrate HPLC peaks for 
each of the P. reptans crude extracts at the chosen wavelengths (data for other 
plants not shown). Under the reverse phased separation system at 210 nm the major 
components appear to be polar compounds eluting in the first 5 min. At 254 nm a 
further series of smaller peaks are present in the subsequent 20 min. At 320 nm the 
sensitivity is poor and many of the peaks seen at 254 nm and 210 nm are not visible.  
The  HPLC-PCA map or scores plot of principal component 1 (PC1) versus PC2 at 
210 nm represents the distribution of samples in multivariate space showing tight 
clustering for the triplicates of each extract thus demonstrating good reproducibility 
between HPLC injections and high quality raw data (Fig. 3.). Each file contained 
6000 discrete regions with data acquisition occurring every second from 0.00 to 
40.00 min giving a total of 72 samples for each plant (24 per selected wavelength). 
The distribution of samples shows those with similar composition forming clusters 
and the distinct samples as separate entities (Gao et al., 2010). Crude extracts were 
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supervised into three activity groups: those with the most inhibition of growth at 200 
µg/mL considered poor to intermediate inhibitors and the more potent inhibition seen 
in the distinct separations of P. reptans 25% ethanol root at 40 µg/mL and the 75% 
ethanol root at 8 µg/mL. Furthermore, the main variance is due to the 1st 
principalcomponent (PC1, 60%) with PC2 accounting for a further 27%of the 
variance. The contributing variables identified in the loadings plot at 210 nm (not 
shown) located the active metabolites primarily found in the root extracts and as 
HPLC peaks eluting within the first 5 min. The HPLC-PCA score plots for all plants at 
320 nm and 254 nm did not discriminate between active and inactive samples as tightly 
as those in the 210  nm model. 
P. reptans was selected for a MIC screen on the basis that it was the most 
potent plant with under reported phytochemistry. The MICs for several of the extracts 
are given in Table 2 showing the 75% ethanol root extract having the greatest 
inhibitory range of 31.25 µg/mL to 1 mg/mL against S. aureus and for the decoction, 
a MIC50 value of 3.9 µg/mL against E. coli. The wine extractions exhibited the 
weakest activity against all bacterial strains although the wine blank and root wine 
extracts demonstrated a MIC50 of 250 µg/mL against S. aureus as well as the root 
wine having a MIC50 at 1 mg/mL against Gram-negative E. coli (Table 2).   
 
4.  Discussion 
This research has been based on modern English translations of the Anglo-
Saxon medical texts as the authors do not read the vernacular. The initial literature 
search revealed three major herbal texts with the Old English Herbarium selected as 
the most appropriate for starting the selection criteria in that it comprises mainly 
single formulations of plants having multiple applications for different conditions 
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associated with wounds and bacterial infections. Battle wounds and burns were 
commonplace in Anglo-Saxon England (van Arsdall, 2002) and mortality rates were 
high with sword, sling shot and arrow injuries as well as individuals being exposed to 
potential infections from bloody wounds (Hutley and Green, 2009). In the 
phytochemical and pharmacological search a number of the NapralertSM reports 
showed the selected plants to have negative antimicrobial assay results that may be 
interpreted as the plants being inactive; alternatively it may be harsh extraction 
methods degrading the active compounds of the original formulation resulting in little 
or no antimicrobial activity.  
The precise identification of some plant names assigned in the Anglo-Saxon 
medical literature is difficult. The same physical descriptions may apply to more than 
one plant as in burdock and cleavers both having fruiting burs that attach to passers 
by although the two plants are visually very different (Cockayne, 1864). Plants were 
assigned a number of synonyms and in some cases, generic names as in 
‘Personacia’ used to describe large leafed plants of different species including 
burdock, beet and water-lily (Hunt, 1989) or an incorrect illustration being inserted 
after the text had been compiled for illustrated versions of the Old English herbarium 
(van Arsdall, 2002; Voigts, 1979). Plant locations were selected within a radius of 25 
miles of Watford as Oxhey, a village in Watford, was first mentioned in an Anglo-
Saxon Charter of 1007 (British Library: Cotton Nero, D.1,ff.149-61). For true 
botanical authentication all of the plants were harvested whilst in flower during 
August and September 2010/2011. The Old English Herbarium occasionally states 
the month in which a plant is to be harvested as in the case of P. reptans ‘you must 
prepare [collect and save] the plant in August’ (van Arsdall, 2002, p.145). Plant 
extracts were chosen to reflect indigenous preparations of infusion, decoction and 
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wine; 25% ethanol for tinctures commonly prescribed in Western herbal medicine 
and the 75% ethanol extracts to mirror those used in classic phytochemical analysis.  
A. minus (Lesser Burdock) is a biennial similar in appearance and structure to 
A. lappa although smaller forming a rosette in the first year. Flower heads are purple 
with hooked bracts forming burrs appearing July to September. The plant is mainly 
found in lowland central southern England and borders of Wales and is occasionally 
seen in open woods, grassy verges and scrubland (Stace, 2010). Hunt (1989) 
attributes ‘Lappa Eversa’ to both A. lappa and A. minus and in this study, we 
selected the latter as having under reported phytochemistry. A. minus remains in the 
medicinal flora (Barker, 2001) although in contemporary Western herbal practice it 
has been replaced with A. lappa with the UK herbal manufacturers only offering dried 
herb of the aerial parts and 25% ethanol tincture for sale. The plant is currently used 
topically for boils, acne and eczema which is of similar use to some of the Anglo-
Saxon formulations (Table 1). Sanders et al. (1945) report an aqueous juice of A. 
minus aerial parts being active against B. subtilis with an inhibitory zone of 15-25 
mm compared to an inhibitory zone against E. coli of 15-20 mm. Interestingly, they 
commented  that there was a marked stimulation of growth of the test organism in 
many samples which they attributed to plant extract providing growth factors or 
similar compounds. In another antimicrobial study of a disc diffusion assay, a 70% 
ethanol infusion of A. lappa flower at 400 µg/disc exhibited 10-15 mm zone of 
inhibition against S. aureus  and 15-20 mm against B. subtilis with discs of 
streptomycin and chloramphenicol at 30 µg per disc used as the positive control 
(Moskalenko, 1986). The reported literature is similar to our study with A. minus 
showing moderate activity against S. aureus and  E.coli  as well as evidencing the 
stimulation of growth in some extracts (Fig 1). 
 Journal of Ethnopharmacology  15 
 
In comparison with lesser burdock more has been reported on A. eupatoria 
although less for antimicrobial activity. A. eupatoria (Agrimony) is a hairy herbaceous 
perennial with erect stems up to 60 cm with yellow flowers appearing in long spikes 
from June to September. The plant is fairly widespread in the British Isles except 
Northern Scotland and common in hedgerows, grassy pastures and scrubland 
(Rose, 2006 and Stace, 2010). Agrimony is used by herbalists practicing Western 
herbal medicine to treat diarrhoea and urinary and respiratory infections by contrast 
to the many Anglo-Saxon formulations for treating fresh and infected wounds (Table 
1). Copland et al. (2003) reported an A. eupatoria seed hexane extract to have a 
MIC value of 0.75 mg/mL against B. subtilis but no activity against P. aeruginosa or 
E. coli although in Western herbal medicine it is the herb and not the seed that is 
used. In another species, isolated agrimol derivatives from A. pilosa have been 
reported to inhibit the growth of S. aureus with a MIC range of 3.13-50 µg/mL 
(Yamaki et al, 1994). In our antimicrobial screening both aerial and root extracts 
demonstrated moderate inhibition of S. aureus whilst only the root extracts showed 
moderate activity against B. subtilis and E. coli. 
P. reptans commonly known as Creeping Cinquefoil is a low growing 
perennial with slender creeping stems that may be up to 1 m long with small yellow 
flowers appearing on long stalks from June to September. The plant is common in 
the British Isles in hedge banks, roadsides, open grasslands and sand-dunes 
although not so common in Scotland (Stace, 2010). By contrast P. reptans use has 
been superceded by P. erecta although still referenced in Barker’s medicinal flora 
(2001); perhaps an example of economic botany with both A. minus and P. reptans 
being substituted and later replaced by larger and more abundant counterparts. In 
the Anglo-Saxon formulations P. reptans is considered to be an effective treatment 
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to ‘prevent a canker spreading’ and with only eight compounds reported to date 
became the target of our study (Table 1). The review by Tomczyk and Latte (2009) 
report antimicrobial compounds for the aerial parts of the plant as kaempferol, 
quercetin-3’-glucoside, quercetin-3,7-O-β-D-glucuronide, isosalipurposide, ellagic 
acid,  p-coumaric acid, caffeic acid and ferulic acid. By contrast a survey of nine 
Potentilla species reported aqueous infusions of aerial parts to inhibit S. aureus 
(ATCC 6538) within a MIC range of 12.5 mg to >100 mg/mL and in the same study, 
P. argenta L. was the most potent against Gram-negative bacteria by inhibiting E.coli  
(ATCC 25922) at 50 mg/mL and P. aeruginosa (ATCC 27853) at >100 mg/mL 
(Tomczyk et al., 2008).  Antimicrobial activity for P. reptans has only been previously 
reported for the aerial parts but we have shown the root extracts exhibited greater 
inhibition against S. aureus and E. coli than reported in the literature for other 
Potentilla species. The 75% ethanol root extract was the only one to show MIC50 
activity at 1 mg/mL against Gram-negative bacteria  P. aeruginosa and the 
decoction, the only one with a MIC50 at 3.90 µg/mL inhibiting growth of E. coli (Table 
2) highlighting that there may be more than one active antimicrobial compound 
present in the two different extracts. 
Often the Anglo-Saxon formulations specify ‘old or aged wine.’ Hagen (2006) 
states that wine was only for the elite and the majority of people in England would 
have used ale or produced fruit wines including mulberry, blackberry, raspberry and 
elderberry. The extracts were made using wine at room temperature as many of the 
formulations instruct to mix with herb and use. Some preparations specifically state 
that the wine must be boiled but this was not tested in this study.  
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Many of the herbal preparations for treating wounds and bacterial infections 
appear pragmatic and in context for the given condition and the compilers of the 
Anglo-Saxon herbal literature were often convinced of a good outcome by stating 
‘...then it soon healeth’ at the end of a formulation (Table 1). The main unknown is 
strength of preparation although it is believed that the Anglo-Saxon practitioner was 
trained to administer varying doses as seen in the preparation of ‘dwale’ a 
stupefactive (plants not specified) prepared as an anaesthetic and given to drink until 
the patient falls asleep (Voigts and Hudson, 1994). In line with the British Herbal 
Pharmacopoeia (1996) a typical daily dose for an infusion would be 2-4 g dried herb 
three times a day which equates to drinking  2-3 cups (500- 750 mL) of herbal tea. In 
our study of P. reptans an infusion of 2 g of aerial parts yielded 285 mg of dried 
extract which would equate to 285-570 mg of dried herb per cup compared to the 
decoction yield of 1232–2464 mg per cup (data not shown). 
In this study the P. reptans root extracts have demonstrated greater MIC 
values against S. aureus, P. aeruginosa and E. coli than those reported for other 
Potentilla species showing that the plants no longer used in practice would have 
been suitable substitutes. MIC values of 50% and 90% inhibition of growth were 
used to show the range of inhibitory activity against the wound pathogens. There 
may be more than one active compound as the mode of antimicrobial activity in the 
75% ethanol root extract against S. aureus is bactericidal whereas the root decoction 
at the MIC concentrations exhibited a bacteriostatic action against  E.coli. To date 
there is no evidence in the literature reporting which compounds may be responsible 
for the antimicrobial activity of P. reptans. The HPLC-PCA map was used to 
determine the quality of the data as well as discern different HPLC peaks between 
extracts that may account for the antimicrobial activity. This technique has been 
 Journal of Ethnopharmacology  18 
 
previously used to group plants based on their chemical profiles in order to 
determine compounds that contributed to pharmacological activity (Li et al., 2012; 
Sharma et al., 2012). The loading plot (not shown) confirmed that the differences in 
activity of the 75% ethanol extract and root decoction were due to the major peaks 
seen in the first five minutes at 210 nm. This suggests that should the HPLC method 
be optimised to isolate the nominated peaks, the fractions will potentially be active 
antimicrobial compounds; a method that has been previously demonstrated by Gao 
et al. (2010) using secondary metabolite mapping to identify inhibitors of lung cancer 
cells. 
Interestingly, the data for this study has been compiled using less than 30 g of 
dried plant for each species demonstrating that very little material is needed to obtain 
scientific evidence from modern analytical methods compared to classic 
phytochemical extraction processes. These typically use 500-1000 g for an initial 
screening of one plant which clearly has implications for conservation of those less 
common native plants where the root is specified in the Anglo-Saxon formulations. 
Based on our own work, the Anglo-Saxon texts have shown to be a good source for 
rediscovering plants lost to current herbal practice  and, in particular, those used to 
treat bacterial infections and wounds could be further studied for related anti-
inflammatory activity. 
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Figure Captions 
 
Fig. 1. Antimicrobial screening of A. eupatoria, A. minus and P. reptans extracts 
expressed as a percentage of inhibition against S. aureus.  
Fig. 2. HPLC-diode array chromatogram overlays of P. reptans crude extracts at 320 
(top), 254 (middle) and 210 nm (lower). 
Fig. 3.  HPLC-PCA score plot of P. reptans extracts at 210 nm (top) confirming the 
active extracts on the left hand side of the plot and the loadings plot for 75% ethanol 
extract (bottom). 
 
